A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 3, 2017

Primary Completion Date

December 6, 2017

Study Completion Date

December 6, 2017

Conditions

Alzheimer Disease

Interventions

DRUG

KHK6640

Intravenous administration

DRUG

Placebo

Intravenous administration

Trial Locations (1)

Closed information, Saitama

All Listed Sponsors

lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT03093519 - A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter